KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas
- PMID: 26083571
- PMCID: PMC4470527
- DOI: 10.1097/NEN.0000000000000213
KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas
Abstract
Up to 20% of patients with pilocytic astrocytoma (PA) experience a poor outcome. BRAF alterations and Fibroblast growth factor receptor 1 (FGFR1) point mutations are key molecular alterations in Pas, but their clinical implications are not established. We aimed to determine the frequency and prognostic role of these alterations in a cohort of 69 patients with PAs. We assessed KIAA1549:BRAF fusion by fluorescence in situ hybridization and BRAF (exon 15) mutations by capillary sequencing. In addition, FGFR1 expression was analyzed using immunohistochemistry, and this was compared with gene amplification and hotspot mutations (exons 12 and 14) assessed by fluorescence in situ hybridization and capillary sequencing. KIAA1549:BRAF fusion was identified in almost 60% of cases. Two tumors harbored mutated BRAF. Despite high FGFR1 expression overall, no cases had FGFR1 amplifications. Three cases harbored a FGFR1 p.K656E point mutation. No correlation was observed between BRAF and FGFR1 alterations. The cases were predominantly pediatric (87%), and no statistical differences were observed in molecular alterations-related patient ages. In summary, we confirmed the high frequency of KIAA1549:BRAF fusion in PAs and its association with a better outcome. Oncogenic mutations of FGFR1, although rare, occurred in a subset of patients with worse outcome. These molecular alterations may constitute alternative targets for novel clinical approaches, when radical surgical resection is unachievable.
Figures
Similar articles
-
Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.Brain Pathol. 2017 Sep;27(5):580-589. doi: 10.1111/bpa.12444. Epub 2017 Jan 6. Brain Pathol. 2017. PMID: 27608415 Free PMC article.
-
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.Acta Neuropathol. 2016 Jun;131(6):833-45. doi: 10.1007/s00401-016-1539-z. Epub 2016 Jan 25. Acta Neuropathol. 2016. PMID: 26810070 Free PMC article.
-
[Clinicopathological Study of Pilomyxoid-Spectrum Astrocytomas:An Analysis of the BRAF Gene. Report of Two Cases].No Shinkei Geka. 2015 Sep;43(9):825-33. doi: 10.11477/mf.1436203129. No Shinkei Geka. 2015. PMID: 26321697 Review. Japanese.
-
Molecular characterization of disseminated pilocytic astrocytomas.Neuropathol Appl Neurobiol. 2016 Apr;42(3):273-8. doi: 10.1111/nan.12256. Epub 2015 Jul 20. Neuropathol Appl Neurobiol. 2016. PMID: 26084390
-
Pilocytic astrocytoma: a disease with evolving molecular heterogeneity.J Child Neurol. 2013 May;28(5):625-32. doi: 10.1177/0883073813476141. Epub 2013 Feb 25. J Child Neurol. 2013. PMID: 23439714 Review.
Cited by
-
New CNS tumor classification: The importance in pediatric neurosurgical practice.Surg Neurol Int. 2024 Apr 12;15:130. doi: 10.25259/SNI_681_2023. eCollection 2024. Surg Neurol Int. 2024. PMID: 38742003 Free PMC article. Review.
-
Noninvasive Molecular Subtyping of Pediatric Low-Grade Glioma with Self-Supervised Transfer Learning.Radiol Artif Intell. 2024 May;6(3):e230333. doi: 10.1148/ryai.230333. Radiol Artif Intell. 2024. PMID: 38446044 Free PMC article.
-
Pilocytic astrocytoma: The paradigmatic entity in low‑grade gliomas (Review).Oncol Lett. 2024 Feb 8;27(4):146. doi: 10.3892/ol.2024.14279. eCollection 2024 Apr. Oncol Lett. 2024. PMID: 38385109 Free PMC article. Review.
-
Pediatric low-grade glioma models: advances and ongoing challenges.Front Oncol. 2024 Jan 22;13:1346949. doi: 10.3389/fonc.2023.1346949. eCollection 2023. Front Oncol. 2024. PMID: 38318325 Free PMC article. Review.
-
Pathological perspectives in pilocytic astrocytomas: Extent of resection as the sole critical factor for recurrence-free survival, and the challenge of evaluating conclusions derived from limited data.Free Neuropathol. 2023 Oct 20;4:4-17. doi: 10.17879/freeneuropathology-2023-5116. eCollection 2023 Jan. Free Neuropathol. 2023. PMID: 37901684 Free PMC article.
References
-
- Scheithauer BW, Hawkins C, Tihan T, et al. Pilocytic astrocytoma. In: David N, Louis MD, Hiroko Ohgaki PD, Otmar D, Wiestler MD, Webster K, Cavenee PD, editors. WHO Classification of Tumours of the Central Nervous System. World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2007: 13– 21
-
- Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014; 64: 83– 103 - PubMed
-
- Camargo Bd, Felipe CFP, Noronha CP, et al. Câncer na criança e no adolescente no Brasil dados dos registros de base populacional e de mortalidade. Rio de Janeiro: Instituto Nacional do Câncer, 2008
-
- Rosemberg S, Fujiwara D. Epidemiology of pediatric tumors of the nervous system according to the WHO 2000 classification: a report of 1,195 cases from a single institution. Child Nerv Sys 2005; 21: 940– 4 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous